PharmaSmart’s president, SVP join pharmacy school’s advisory council
ROCHESTER, N.Y. Two executives from blood pressure screening equipment manufacturer PharmaSmart International have joined the Wegmans School of Pharmacy’s advisory council, PharmaSmart said Wednesday.
President Fred Sarkis and SVP and general manager Ashton Maaraba will work with the council to help plan and initiate new academic and extracurricular opportunities for the school and began their term by donating blood pressure screening equipment and Web services to the school for students to use in their studies.
“Ashton and I are very excited to become part of this prestigious committee, and we hope that our grant and continuing support make a difference for the students, faculty and the School of Pharmacy,” Sarkis said.
Natural Products Association responds to GAO’s ‘secret shopper’ investigation
WASHINGTON The Government Accountability Office on Wednesday presented to a congressional panel the results of a “secret shopper” investigation, which found that in a number of retail establishments visited, the salesperson made inappropriate or illegal claims about dietary supplements.
The investigation results have drawn response from industry group the Natural Products Association, which said misleading customers is “not acceptable.”
“The Natural Products Association has always made clear through numerous channels including educational materials available on our Web site, and education at our tradeshow, that if a retail salesperson is misleading customers, offering medical diagnoses, or making drug claims about supplements, then that is a violation of the law –– no ifs, ands, or buts,” stated John Gay, NPA executive director and CEO. “While the findings of the GAO may be explained by turnover common in the retail sector, or by new retailers entering the market unaware of their obligations; any violation of the law is not acceptable.”
Accordingly, the NPA has announced an expanded effort to educate and train retailers and their staffs on what can and cannot be said to customers. This effort initially will include the following:
• Development of a “tool kit” for retailers to use to train their staffs;• expanded training programs including live sessions at trade shows, Webinars, and teleconferences;• Partnerships with industry media to broaden the reach of educational materials;• More frequent and regular content on rules for salespeople in NPA publications and communications; and• Development of a dedicated Web page with education and training materials to serve salespeople, retailers, and customers.
Dietary supplement legislation receives support from CRN, NPA
WASHINGTON Sens. Tom Harkin, D-Iowa, and Orrin Hatch, R-Utah, on Tuesday introduced the Dietary Supplement Full Implementation and Enforcement Act of 2010, a piece of legislation designed to provide the Food and Drug Administration with additional enforcement resources.
Each of the leading trade associations representing the supplement industry issued their support behind the bill.
“[The Council for Responsible Nutrition] applauds Sens. Tom Harkin and Orrin Hatch for their efforts to fully fund, implement and enforce the Dietary Supplement Health and Education Act of 1994,” stated Steve Mister, CRN president and CEO. “CRN and its member companies have long advocated for more resources to help the FDA better enforce industry regulation, and this bill is a step in the right direction to making that happen.”
John Gay, executive director and CEO of the Natural Products Association added, “While some have called for additional regulations on supplements, Sens. Harkin and Hatch understand that the real need is to fully enforce the stringent statutes already on the books, to the full extent of the law. The way to get the bad actors out of the industry is by putting more cops on the street, plain and simple.”
This legislation reinforces the authority FDA has to regulate the supplement industry under DSHEA, and ensures the agency has additional resources to more fully implement that authority. The bill would provide FDA with additional resources over a five-year period to accomplish important regulatory mandates set out by DSHEA, including:
- Assuring that manufacturing facilities are GMP compliant through additional facility inspections;
- Calling on FDA to issue clear guidance for new dietary ingredients and the submission of these NDI notifications, as well as the criteria for establishing a reasonable expectation of safety for these ingredients;
- Implementing an annual registration process for supplement manufacturers, packers and distributors;
- Requiring more dialogue between FDA and the Drug Enforcement Administration so that anabolic steroids or their analogues do not reach consumers as a mislabeled supplement; and
- Developing appropriate consumer education initiatives that will create more informed supplement customers.